48.41
Gsk Plc Adr Aktie (GSK) Neueste Nachrichten
J.P. Morgan Maintains a Sell Rating on GSK plc (GSK) - Finviz
Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer - GlobeNewswire Inc.
GSK Stock Near 52-Week Highs: Upgraded 2025 Guidance, Buybacks and Zantac Relief Fuel Re‑Rating - ts2.tech
GSK plc Stock in December 2025: Buybacks, New CEO and Strong Q3 Results Drive a 40% Rally - ts2.tech
GSK Stock Outlook December 2025: Q3 Beat, Buybacks and Big FDA Decisions Shape 2026 Forecasts - ts2.tech
AstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report - Sahm
Analysts Offer Predictions for GSK's Q2 Earnings (NYSE:GSK) - MarketBeat
Quantbot Technologies LP Has $5.33 Million Stock Holdings in GSK PLC Sponsored ADR $GSK - MarketBeat
GSK Stock Near 52‑Week High as FDA Decisions and CEO Transition Loom (LON:GSK, NYSE:GSK) - ts2.tech
Here's Why GSK (GSK) is a Strong Growth Stock - Yahoo Finance
GSK PLC Sponsored ADR $GSK Shares Acquired by Fisher Asset Management LLC - MarketBeat
GSK plc Stock Today: Q3 Beat, Blenrep Comeback and a New CEO – Full Investor Update for 2 December 2025 - ts2.tech
GSK Stock on 1 December 2025: Big 2025 Rally, Blenrep’s Comeback and a New CEO – What Investors Need to Know Now - ts2.tech
GSK PLC Sponsored ADR (NYSE:GSK) Receives Average Rating of “Hold” from Analysts - Defense World
GSK plc Stock Today, 28 November 2025: Buybacks, ‘Hold’ Ratings and Pipeline Momentum Keep Shares Near Highs - ts2.tech
GSK PLC Sponsored ADR (NYSE:GSK) Receives Average Rating of "Hold" from Analysts - MarketBeat
Rep. Lisa C. McClain Sells Off Shares of GSK PLC Sponsored ADR (NYSE:GSK) - Defense World
Looking To Buy GSK Plc ADR (GSK)? Read This First - fostersleader.com
GSK News Today (26 November 2025): Medicare Slashes Prices on Trelegy, Berenberg Lifts Target, and Buybacks Signal Confidence - ts2.tech
Rep. Lisa C. McClain Buys GSK PLC Sponsored ADR (NYSE:GSK) Stock - MarketBeat
Barclays PLC Share Price Today, 25 November 2025: BARC Jumps Above 409p as UK Budget Tax Fears Ease - ts2.tech
GSK (NYSE:GSK) Stock Unloaded Rep. Lisa C. McClain - Defense World
SG Americas Securities LLC Has $995,000 Stock Holdings in GSK PLC Sponsored ADR $GSK - MarketBeat
Zacks Research Issues Pessimistic Estimate for GSK Earnings - Defense World
Why GSK (GSK) is a Top Value Stock for the Long-Term - Yahoo Finance
Zacks Research Weighs in on GSK’s FY2025 Earnings (NYSE:GSK) - Defense World
JPMorgan Lowers GSK Price Target, Maintains Underweight Rating - Finviz
Alector Stock Plummets 63% in a Month: Here's What You Need to Know - Finviz
Eli Lilly Upgraded, Chewy Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
GSK PLC Share Price: What to Know Before the London Market Opens on 17 November 2025 - ts2.tech
GILD's Investigational Regimen for HIV Treatment Meets Primary Goal - Finviz
The Best Healthcare Stock to Hold in Uncertain Times - Finviz
Why GSK (GSK) is a Top Growth Stock for the Long-Term - Yahoo Finance
GSK (NYSE:GSK) Sets New 12-Month HighTime to Buy? - MarketBeat
Looking Into GSK PLC's Recent Short Interest - Sahm
3 Dividend Stocks for November 2025 - Morningstar
10 Best Value Stocks to Buy for the Long Term - Morningstar
GSK PLC Sponsored ADR (NYSE:GSK) Given Average Rating of "Hold" by Analysts - MarketBeat
Arkadios Wealth Advisors Acquires 6,734 Shares of GSK PLC Sponsored ADR $GSK - MarketBeat
GSK PLC Sponsored ADR Plans Quarterly Dividend of $0.42 (NYSE:GSK) - MarketBeat
GSK's Vaccine and HIV Portfolios Support Ongoing Innovation in Oncology and Immunology - Morningstar
GSK's Q3 Earnings & Sales Beat Estimates, Stock Up on Raised '25 View - TradingView
GSK Upgrades 2025 Financial Outlook, CEO Says Positioned Well For 2026 - Sahm
ETFs Investing in GSK plc Sponsored ADR Stocks - TradingView
Whittier Trust Co. Sells 5,805 Shares of GSK PLC Sponsored ADR $GSK - MarketBeat
GSK plc Sponsored ADR (GSK) Stock Forecast & Price Targets: Today, Tomorrow, Next Week - Traders Union
GSK plc Sponsored ADR (GSK) Stock Price Prediction for 2025, 2026, 2030-2040 - Traders Union
FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep - Sahm
J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK) - The Globe and Mail
GSK PLC Sponsored ADR $GSK Shares Acquired by Ethic Inc. - MarketBeat
Clinical Failure Halts Alector's Dementia Program, Company Reduces Workforce - Sahm
GSK (GSK) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Nasdaq
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):